The Latest Options and Future Agents for Treating Male Hypogonadism

November 2007 in “ Expert Opinion on Pharmacotherapy ”

Daniel L. Edelstein, Mala S. Sivanandy, Sadeka Shahani, Shehzad Basaria

testosterone replacement therapy TRT testosterone gels testosterone patches testosterone injections hypogonadism pharmacological agents testosterone therapy testosterone gel testosterone patch testosterone shot

TLDR New and future treatments for male hypogonadism include various forms of testosterone therapy and emerging drugs.

The document reviewed the latest treatment options and potential future agents for male hypogonadism as of 2007. It discussed various therapies, including testosterone replacement therapy (TRT) in different forms such as gels, patches, and injections. The review also highlighted the importance of individualized treatment plans based on patient-specific factors and the need for ongoing monitoring to manage potential side effects. Additionally, the authors explored emerging treatments and the potential for new pharmacological agents that could offer more targeted and effective management of hypogonadism in the future.

View this study on tandfonline.com →

Discuss this study in the Community →

Cited in this study

3 / 3 results

research Design, Synthesis, and Biological Characterization of Metabolically Stable Selective Androgen Receptor Modulators

129 citations, January 2004 in “Journal of medicinal chemistry”

Researchers developed new compounds that target the androgen receptor effectively with fewer side effects.

research The Effects of Transdermal Dihydrotestosterone in the Aging Male: A Prospective, Randomized, Double-Blind Study

110 citations, April 2002 in “The Journal of clinical endocrinology and metabolism/Journal of clinical endocrinology & metabolism”

Dihydrotestosterone gel improved well-being and sexual function in older men without negatively affecting prostate health.

Prostate-Sparing Effects in Primates of the Potent Androgen 7α-Methyl-19-Nortestosterone: A Potential Alternative to Testosterone for Androgen Replacement and Male Contraception

research Prostate-Sparing Effects in Primates of the Potent Androgen 7α-Methyl-19-Nortestosterone: A Potential Alternative to Testosterone for Androgen Replacement and Male Contraception

14 citations, December 1998 in “The Journal of Clinical Endocrinology and Metabolism”

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.